What is the debt of Ardelyx this year?
Ardelyx has a debt level of 28.35 USD this year.
Ardelyx Debt 2024
Ardelyx Debt
28.35 USD
Ticker
ARDX
ISIN
US0396971071
WKN
A116X0
In 2024, Ardelyx's total debt was 28.35 USD, a -140.85% change from the -69.4 USD total debt recorded in the previous year.
Ardelyx Aktienanalyse
What does Ardelyx do?
Ardelyx Inc. is a biotechnology company founded in 2007 by researchers to develop life-changing medications. The company is based in Fremont, California, USA and focuses on researching kidney and gastrointestinal diseases, as well as cardiology and metabolic disorders. Its business model is based on identifying unmet medical needs and developing drugs to meet those needs. Ardelyx works closely with patients to understand their medical problems and develop specific solutions. The company categorizes its products into three categories: kidney, gastrointestinal, and cardiology/metabolism. Ardelyx has developed a medication called Tenapanor for chronic kidney disease, which reduces phosphorus levels in the blood, lowering the risk of cardiovascular disease. For gastrointestinal diseases like irritable bowel syndrome and ulcerative colitis, Ardelyx has developed Tenapanor to reduce pain and discomfort by regulating fluid and nutrient volumes in the intestine. In the field of cardiology/metabolic disorders, Ardelyx is working on developing medications to regulate cholesterol levels and the lipid metabolism system, which can be the cause of heart disease or diabetes. The company is awaiting approval for Ibsrela, a medication for chronic constipation and pelvic floor disorders, as well as RDX013, a medication to regulate lipid metabolism. Ardelyx also benefits from collaborating with other pharmaceutical companies, such as AstraZeneca, which has supported the development of novel treatments for kidney diseases. The partnership with AstraZeneca focuses on creating treatments that prevent damage to kidney cells or the cardiovascular system. Ardelyx has also received a number of awards and recognition, demonstrating its effectiveness and performance in the biotechnology industry. For example, in 2019, Inc. Magazine included Ardelyx for the fourth consecutive year in its list of the "5000 fastest-growing private companies in the USA." This publication highlighted Ardelyx's tripling of its employee count during the same period. Overall, Ardelyx focuses on researching and developing innovative medications that meet the needs of patients with kidney, gastrointestinal, cardiology, and metabolic disorders. Despite being a young company, it already produces a range of innovative products and is committed to developing life-changing medications through its research and improving the quality of life for affected patients. Output: Ardelyx Inc. is a biotechnology company focused on developing life-changing medications for kidney, gastrointestinal, cardiology, and metabolic disorders. They collaborate with patients to understand their medical problems and develop specific solutions. They have developed medications such as Tenapanor for chronic kidney disease and gastrointestinal diseases. They are awaiting approval for medications to treat chronic constipation and pelvic floor disorders, as well as regulate lipid metabolism. Ardelyx has partnerships with other pharmaceutical companies like AstraZeneca. They have received awards for their effectiveness and performance in the biotechnology industry. Ardelyx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Ardelyx's Debt Structure
Ardelyx's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Ardelyx's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Ardelyx’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Ardelyx’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Ardelyx stock
What was the debt of Ardelyx compared to the previous year?
The debt of Ardelyx has increased by -140.85% compared to the previous year dropped.
What are the consequences of high debt for investors in Ardelyx?
High debt can pose a risk for investors of Ardelyx, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Ardelyx?
Low debt means that Ardelyx has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Ardelyx affect the company?
An increase in debt of Ardelyx can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Ardelyx affect the company?
A reduction in debt of Ardelyx can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Ardelyx?
Some factors that can influence the debt of Ardelyx include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Ardelyx so important for investors?
The debts of Ardelyx are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Ardelyx take to change the debt?
To change the debt, Ardelyx can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Ardelyx pay?
Over the past 12 months, Ardelyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ardelyx is expected to pay a dividend of 0 USD.
What is the dividend yield of Ardelyx?
The current dividend yield of Ardelyx is .
When does Ardelyx pay dividends?
Ardelyx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ardelyx?
Ardelyx paid dividends every year for the past 0 years.
What is the dividend of Ardelyx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ardelyx located?
Ardelyx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ardelyx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ardelyx from 9/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/24/2024.
When did Ardelyx pay the last dividend?
The last dividend was paid out on 9/24/2024.
What was the dividend of Ardelyx in the year 2023?
In the year 2023, Ardelyx distributed 0 USD as dividends.
In which currency does Ardelyx pay out the dividend?
The dividends of Ardelyx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ardelyx stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ardelyx
Our stock analysis for Ardelyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ardelyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
